Search details
1.
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.
Lancet Oncol
; 16(4): 426-35, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25795408
Results
1 -
1
de 1
1
Next >
>>